Pfizer’s Elranatamab Receives FDA and EMA Filing Acceptance
Go back to Pfizer’s Elranatamab Receives FDA and EMA Filing Acceptance| Pfizer Inc. (NYSE: PFE) | Delayed: 24.25 -0.23 (0.94%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $24.48 | 52 Week High | $37.39 | |||
| Open | $24.37 | 52 Week Low | $28.25 | |||
| Day High | $24.43 | P/E | 14.70 | |||
| Day Low | $24.14 | EPS | $1.65 | |||
| Volume | 19,903,364 | |||||
